Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group62

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group10

Views

Views
August 20252
September 20251
October 20250
November 20252
December 20251
January 20264
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
United Kingdom4
Argentina2
 

Top cities views

Views
Dallas2
Chicago1
Moreno1
Villa Mercedes1